BuSpar Side Effects: Dizziness and What to Do

Buspirone, sold under the discontinued brand name BuSpar, has a reputation among anxiety medications for being gentle: no benzodiazepine-like dependence risk and generally less sedation or next-day fog. It can still cause drowsiness, but its most common early side effect is dizziness. Understanding why dizziness can show up before any anxiety benefit does is the key to sticking with the medication long enough for it to work.

What This Page Covers

• What Buspirone Actually Does
• How Common Dizziness Is in Trial Data
• Why Side Effects Can Arrive Before the Benefit
• Other Common and Serious Side Effects
• How Buspirone Differs From Benzodiazepines
• About Siggy

What Buspirone Actually Does

Buspirone is FDA-approved for generalized anxiety disorder, and it works differently from both benzodiazepines and SSRIs. Its exact mechanism is not fully mapped, but the FDA label describes buspirone as having a high affinity for serotonin 5-HT1A receptors, while showing no significant affinity for benzodiazepine receptors and no effect on GABA binding, the receptor system that benzodiazepines and alcohol both act on. In practical terms, this means buspirone does not exert the muscle-relaxant or strongly sedating effects associated with benzodiazepine anxiolytics, which is part of why it does not carry their dependence risk.

That different mechanism also explains why buspirone’s timeline looks nothing like a benzodiazepine’s. A benzodiazepine can measurably reduce anxiety within an hour. Buspirone’s effect builds gradually, generally requiring several weeks of consistent daily dosing before its anti-anxiety benefit becomes apparent, according to MedlinePlus, the National Institutes of Health’s patient drug information service.

How Common Dizziness Is in Trial Data

Dizziness is not an occasional side effect of buspirone. It is, by a wide margin, the most commonly reported one. In the FDA’s pooled data from 4-week, placebo-controlled trials, dizziness was reported by 12% of buspirone-treated patients compared with 3% of patients on placebo, making it the single most frequently reported adverse event in the drug’s premarketing trials.

That same trial data shows the overall discontinuation rate and what drove it:

Reason for Discontinuation	Approximate Rate
Any adverse event	About 10% of patients
CNS effects (dizziness, insomnia, nervousness, drowsiness)	3.4% of patients
Gastrointestinal effects (mainly nausea)	1.2% of patients
Other effects (mainly headache, fatigue)	1.1% of patients

These figures come from pooled data across 2,200 anxious patients in buspirone’s premarketing efficacy trials, lasting 3 to 4 weeks each. Because CNS effects such as dizziness were the leading reason for stopping treatment, persistent or disruptive symptoms deserve a conversation with the prescriber rather than an assumption that they will resolve on a set schedule.

Why Side Effects Can Arrive Before the Benefit

The mismatch between when side effects show up and when relief shows up is one reason people may consider stopping buspirone early. Dizziness and nausea can occur before the medication’s anxiety benefit becomes noticeable, which generally requires several weeks of consistent dosing according to MedlinePlus.

A 1998 review in the Canadian Journal of Psychiatry examining pharmacologic treatments effective across both generalized anxiety disorder and major depressive disorder noted that buspirone has demonstrated a modest acute antidepressant effect in patients with considerable anxiety at baseline, alongside its anxiolytic action. Experiencing dizziness before anxiety relief does not by itself show whether the medication will ultimately be effective, but severe or persistent symptoms should be discussed with the prescriber.

Other Common and Serious Side Effects

Beyond dizziness, the FDA’s trial data identifies nausea, headache, nervousness, and lightheadedness as the next most frequently reported effects. Their duration varies by person; contact the prescriber if they are severe, persistent, worsening, or interfere with daily activities.

A smaller set of reactions are rare but serious enough to require prompt attention:

• Serotonin syndrome, which can occur when buspirone is combined with other serotonergic medications such as SSRIs, and presents with agitation, rapid heartbeat, muscle rigidity, and fever.
• Allergic reactions, including swelling of the face, lips, tongue, or throat, which need emergency care.
• A restlessness syndrome appearing shortly after starting treatment in a small fraction of patients, which the FDA label notes may relate to buspirone’s effect on dopamine pathways.

None of these are common, but knowing the difference between an expected adjustment symptom and a reason to call for help is what makes the early weeks of buspirone manageable rather than alarming.

How Buspirone Differs From Benzodiazepines

Because buspirone treats the same condition benzodiazepines are often used for, it is worth being specific about how differently the two behave. Buspirone does not act on benzodiazepine receptors, so it is generally less sedating and does not carry the same cognitive slowing or dependence risk associated with regular benzodiazepine use. Drowsiness can still occur, especially while starting or changing a dose. Buspirone also does not produce a recognized withdrawal syndrome the way benzodiazepines do, though stopping it abruptly can temporarily worsen anxiety symptoms for some people, which is why any change to the regimen should go through a prescriber.

The tradeoff for that safety profile is speed. Benzodiazepines act within an hour but carry dependence risk with regular use. Buspirone takes weeks to build a benefit, and dizziness or nausea may occur during treatment even though it does not carry that same dependence risk.

About Siggy

The gap between when buspirone’s side effects show up and when its benefit does is exactly the kind of pattern that is easy to misread alone and easy to miss entirely without regular check-ins. Someone who feels dizzy and nauseated without anxiety relief yet can reasonably wonder if the medication is working against them rather than for them.

Siggy is built to track that adjustment period alongside a licensed prescriber, so early side effects get education and context in real time instead of getting discovered, and possibly acted on by quitting, weeks before the benefit was ever going to show up. If you’re managing anxiety and want that kind of support built into your care from day one, start your anonymous intake with Siggy.